Outset Medical, Inc. (OM)

[falon]

Outset Medical to Present at 42nd Annual Cowen Health Care Conference


SAN JOSE, Calif.--(BUSINESS WIRE)--Feb. 22, 2022-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.


About Outset Medical, Inc.


Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

https://investors.outsetmedical.com/news-releases/news-release-details/outset-medical-present-42nd-annual-cowen-health-care-conference